Questions discussed in this category
How is this entity distinct from other secondary HLH entities?
Would the answer differ if the index event was arterial vs venous?
This type of etoposide sparing therapy has been previously described in a case series at https://pubmed.ncbi.nlm.nih.gov/32725881/
If so, how long after diagnosis do you do so?
14670162251618616217161951542912302992012328
Papers discussed in this category
Arthritis Rheumatol, 2019 Dec 26
Autoimmun Rev, 2017 Sep 09
Pediatric blood & cancer, 2011-01
Ther Adv Musculoskelet Dis, 2020 Nov 24